"IL2" の関連情報検索結果
News
Q&A
Shopping
Auction
Rakuten
amazonαTIGIT-IL2 achieves tumor regression by promoting tumor-infiltrating regulatory T cell fragility ...
IL-2 and GLP-1 receptor agonist combination tackles neuroinflammation - Drug Target Review
IL-2 and GLP-1 receptor agonist combination tackles neuroinflammation Drug Target Review
Korean War Flight Simulator Korea: IL-2 Series Lands on Steam With New Page - Simulation Daily
Korean War Flight Simulator Korea: IL-2 Series Lands on Steam With New Page Simulation Daily
FDA Clears IND for GL-IL2-138 in Cancer and Beyond - Targeted Oncology
FDA Clears IND for GL-IL2-138 in Cancer and Beyond Targeted Oncology
Bispecific cytokine delivers for Innovent at last | ApexOnco - Clinical Trials news and analysis ...
Bispecific cytokine delivers for Innovent at last | ApexOnco - Clinical Trials news and analysis Oncology Pipeline
Aulos looks to Phase III for IL-2 mAb in NSCLC and melanoma - Clinical Trials Arena
Aulos looks to Phase III for IL-2 mAb in NSCLC and melanoma Clinical Trials Arena
An immune competent in vitro model of IL2 induced vascular leakage enables mechanistic insights a...
Maintenance results boost Nektar's case for IL-2 agonist in atopic dermatitis - FirstWord Pharma
Maintenance results boost Nektar's case for IL-2 agonist in atopic dermatitis FirstWord Pharma
Genetic Leap receives FDA IND clearance for first-in-class, oral natural IL-2 modulator - PR News...
Genetic Leap receives FDA IND clearance for first-in-class, oral natural IL-2 modulator PR Newswire
First-in-Class IL-2 Pathway Agonist Advances in AD - Dermatology Times
First-in-Class IL-2 Pathway Agonist Advances in AD Dermatology Times
PD-1 + IL-2 power couple: Wake up 'sleepy' T cells to turbo-charge cancer cures - EurekAlert!
PD-1 + IL-2 power couple: Wake up 'sleepy' T cells to turbo-charge cancer cures EurekAlert!
Korea. IL2 Series - Official Gameplay Trailer - IGN
Novel IL-2 Therapy Combo Yields Initial Responses in Nonsquamous NSCLC - CancerNetwork
Novel IL-2 Therapy Combo Yields Initial Responses in Nonsquamous NSCLC CancerNetwork
Nektar says IL-2 pathway agonist rejected by Lilly succeeds in atopic dermatitis trial - FirstWor...
Nektar says IL-2 pathway agonist rejected by Lilly succeeds in atopic dermatitis trial FirstWord Pharma
A cautionary tale for clinical trial collaborators - Oncology Pipeline
A cautionary tale for clinical trial collaborators Oncology Pipeline
TIM3-blockade synergizes with IL2 in alleviating intra-tumoral CD8+T cell exhaustion | Nature Com...
Myelin-specific IL2 + T-cells are associated with last occurring relapse severity in relapsing–re...
In Silico tool for predicting, designing and scanning IL-2 inducing peptides | Scientific Reports...
In Silico tool for predicting, designing and scanning IL-2 inducing peptides | Scientific Reports Nature
IL2Pepscan: A machine learning framework for predicting IL-2 inducing peptides and their identifi...
Long-acting IL-2 release from pressure-fused biomineral tablets promotes antitumor immune respons...
Long-acting IL-2 release from pressure-fused biomineral tablets promotes antitumor immune response Nature
Expression of an interleukin-2 partial agonist enhances regulatory T cell persistence and efficac...
The role of IL-2 in type 2 immunity - Frontiers
The role of IL-2 in type 2 immunity Frontiers
Korea. IL-2 Series Reveals Post-Launch Content Roadmap - Bleeding Cool News
Korea. IL-2 Series Reveals Post-Launch Content Roadmap Bleeding Cool News
PD-1 x IL-2 antibody fusions: The next Keytruda competitors? - BioCentury
PD-1 x IL-2 antibody fusions: The next Keytruda competitors? BioCentury
Low-dose IL-2 therapy reduces arterial inflammation in acute coronary syndromes - Nature
Low-dose IL-2 therapy reduces arterial inflammation in acute coronary syndromes Nature
An in situ engineered chimeric IL-2 receptor potentiates the tumoricidal activity of proinflammat...
New IL-2: Korea Gameplay Footage Released - FSElite
FDA Clears IND Application for Novel IL-2 Agent in Advanced NSCLC - CancerNetwork
FDA Clears IND Application for Novel IL-2 Agent in Advanced NSCLC CancerNetwork
A distinct priming phase regulates CD8 T cell immunity by orchestrating paracrine IL-2 signals - ...
A distinct priming phase regulates CD8 T cell immunity by orchestrating paracrine IL-2 signals Science | AAAS
1C Game Studios Presents "Korea. IL-2 Series" and Talks About the Future of the Series - IXBT.games
1C Game Studios Presents "Korea. IL-2 Series" and Talks About the Future of the Series IXBT.games
Innovent gives another cytokine a shot | ApexOnco - Clinical Trials news and analysis - Oncology ...
Innovent gives another cytokine a shot | ApexOnco - Clinical Trials news and analysis Oncology Pipeline
New Flight Sim Wants You Broke To Get Above Minimum Spec - DualShockers
New Flight Sim Wants You Broke To Get Above Minimum Spec DualShockers
1CGS Unveils Extended Support for Il-2 Sturmovik as Korea Hits Steam - DualShockers
1CGS Unveils Extended Support for Il-2 Sturmovik as Korea Hits Steam DualShockers
Brain-infiltrating ILC2s boost poststroke angiogenic initiation through α-CGRP production - Rocke...
Brain-infiltrating ILC2s boost poststroke angiogenic initiation through α-CGRP production Rockefeller University Press
Examining the evidence for IL-2 in amyotrophic lateral sclerosis - The Lancet
Examining the evidence for IL-2 in amyotrophic lateral sclerosis The Lancet
Biomineral tablets for long-acting IL-2 immunotherapy - Nature
Biomineral tablets for long-acting IL-2 immunotherapy Nature
Adding low-dose IL-2 to riluzole may improve survival in ALS - ALS News Today
Adding low-dose IL-2 to riluzole may improve survival in ALS ALS News Today
Korea. IL-2 Series - IGN Africa
Korea. IL-2 Series IGN Africa
[ESMO 2025] GI Innovation’s IL-2 therapy shows tumor response in ICB-resistant cancers - koreabio...
[ESMO 2025] GI Innovation’s IL-2 therapy shows tumor response in ICB-resistant cancers koreabiomed.com
Mural risks going to the wall as IL-2 flop triggers 90% staff reduction, hunt for strategic alter...
Mural risks going to the wall as IL-2 flop triggers 90% staff reduction, hunt for strategic alternatives Fierce Biotech
Korea. IL-2 Series - IGN France
Korea. IL-2 Series IGN France
Korea. IL-2 Series - Official Pre-Order Trailer - IGN India
iLeukon Receives FDA Clearance of IND Application for A Phase II Study of mRNA-based non-alpha IL...
Topline atopic dermatitis data showcase IL-2 modulator’s ‘incredibly novel’ mechanism - Healio
Topline atopic dermatitis data showcase IL-2 modulator’s ‘incredibly novel’ mechanism Healio
Korea. IL-2 Series - Official Pre-Order Trailer - IGN Africa
Low-dose interleukin-2 for recurrent early pregnancy loss: a proof-of-concept study - medRxiv
Low-dose interleukin-2 for recurrent early pregnancy loss: a proof-of-concept study medRxiv
"Korea. IL-2 series" creators told about aircraft customization - IXBT.games
"Korea. IL-2 series" creators told about aircraft customization IXBT.games
Korea. IL-2 Series Releases New Gameplay Trailer - Bleeding Cool News
Korea. IL-2 Series Releases New Gameplay Trailer Bleeding Cool News
Awareness of TIL Therapy for Melanoma Is Crucial for Timely Referral - Targeted Oncology
Awareness of TIL Therapy for Melanoma Is Crucial for Timely Referral Targeted Oncology
Korea. IL-2 Series - IGN India
Korea. IL-2 Series IGN India
Flight sim "Korea. IL-2 series" developers dived to the ground and showed local residents - IXBT....
Flight sim "Korea. IL-2 series" developers dived to the ground and showed local residents IXBT.games
Creators of the "Korea. IL-2 Series" flight simulator showed the cockpit of the F-84E "Thunderjet...
Coya Therapeutics Announces Results of Investigator-Initiated Study of LD IL-2 and CTLA4-Ig Demon...
A cytokine receptor-masked IL2 prodrug selectively activates tumor-infiltrating lymphocytes for p...
BCANTT 2024: Rationally Engineered IL2 for Enhanced Treatment of Local and Metastatic Bladder Can...
BCANTT 2024: Rationally Engineered IL2 for Enhanced Treatment of Local and Metastatic Bladder Cancer UroToday
Teva's Breakthrough Cancer Immunotherapy Gains Momentum with Major Asian Market Partnership - Sto...
Teva's Breakthrough Cancer Immunotherapy Gains Momentum with Major Asian Market Partnership Stock Titan
PD-1 combination therapy with IL-2 modifies CD8+ T cell exhaustion program - Nature
PD-1 combination therapy with IL-2 modifies CD8+ T cell exhaustion program Nature
A split, conditionally active mimetic of IL-2 reduces the toxicity of systemic cytokine therapy -...
A split, conditionally active mimetic of IL-2 reduces the toxicity of systemic cytokine therapy Nature
Authors of \"Korea. IL-2 Series\" Showed Graphics Settings, Interface, and Highly Detailed Map - ...
Authors of \"Korea. IL-2 Series\" Showed Graphics Settings, Interface, and Highly Detailed Map IXBT.games
Harnessing IL-2 for immunotherapy against cancer and chronic infection: a historical perspective ...
IL-2 treatment can be dangerous. How can drug firms tackle its challenges? - Chemical & Engineeri...
IL-2 treatment can be dangerous. How can drug firms tackle its challenges? Chemical & Engineering News
Coya Therapeutics Announces Completion of Patient Enrollment of an Investigator-Initiated, Open-L...
Crystal structure of the IL-2 signaling complex: Paradigm for a heterotrimeric cytokine receptor ...
Crystal structure of the IL-2 signaling complex: Paradigm for a heterotrimeric cytokine receptor PNAS
PGE2 inhibits TIL expansion by disrupting IL-2 signalling and mitochondrial function - Nature
PGE2 inhibits TIL expansion by disrupting IL-2 signalling and mitochondrial function Nature
Scientists Identify Key Biomarkers That May Predict Low-Dose IL-2 Treatment Efficacy in People wi...
Scientists Identify Key Biomarkers That May Predict Low-Dose IL-2 Treatment Efficacy in People with Systemic Lupus Erythematosus Lupus Foundation of America
A glimpse into the application of the immunomodulatory effect of IL-2 in systemic lupus erythemat...
Proximity-enabled covalent binding of IL-2 to IL-2Rα selectively activates regulatory T cells and...
A single-agent fusion of human IL-2 and anti-IL-2 antibody that selectively expands regulatory T ...
Interleukin-2 Inhibitors Clinical Trial Pipeline - GlobeNewswire
Interleukin-2 Inhibitors Clinical Trial Pipeline GlobeNewswire
New Houston biotech co. developing capsules for hard-to-treat tumors - InnovationMap
New Houston biotech co. developing capsules for hard-to-treat tumors InnovationMap
Engineered E. coli Nissle 1917 for delivery of bioactive IL-2 for cancer immunotherapy - Nature
Engineered E. coli Nissle 1917 for delivery of bioactive IL-2 for cancer immunotherapy Nature
De novo design of potent and selective mimics of IL-2 and IL-15 - Nature
De novo design of potent and selective mimics of IL-2 and IL-15 Nature
A bispecific antibody agonist of the IL-2 heterodimeric receptor preferentially promotes in vivo ...
Targeting tumor microenvironment with antibody-guided IL-2 pro-cytokine promotes and rejuvenates ...
An engineered IL-2 partial agonist promotes CD8+ T cell stemness - Nature
An engineered IL-2 partial agonist promotes CD8+ T cell stemness Nature
Mural hits a wall | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline
Mural hits a wall | ApexOnco - Clinical Trials news and analysis Oncology Pipeline
Regulatory T cells use heparanase to access IL-2 bound to extracellular matrix in inflamed tissue...
Regulatory T cells use heparanase to access IL-2 bound to extracellular matrix in inflamed tissue Nature
Medicenna Targets Pivotal 2026 as IL-2 Superkine Programs Advance Toward Registrational Trials - ...
Medicenna Targets Pivotal 2026 as IL-2 Superkine Programs Advance Toward Registrational Trials TipRanks
CD301b+ dendritic cell-derived IL-2 dictates CD4+ T helper cell differentiation | Nature Communic...
Low-dose IL-2 enhances the generation of IL-10-producing immunoregulatory B cells - Nature
Low-dose IL-2 enhances the generation of IL-10-producing immunoregulatory B cells Nature
T cell frequency and induces anti-inflammatory gene expression in type 1 diabetes - Nature
T cell frequency and induces anti-inflammatory gene expression in type 1 diabetes Nature
Effects of rIL2/anti-IL2 antibody complex on chikungunya virus-induced chronic arthritis in a mou...
IL-2 delivery by engineered mesenchymal stem cells re-invigorates CD8 - Nature
IL-2 delivery by engineered mesenchymal stem cells re-invigorates CD8 Nature
An engineered IL-2 reprogrammed for anti-tumor therapy using a semi-synthetic organism - Nature
An engineered IL-2 reprogrammed for anti-tumor therapy using a semi-synthetic organism Nature
Measurement of IFN-γ and IL-2 for the assessment of the cellular immunity against SARS-CoV-2 - Na...
Measurement of IFN-γ and IL-2 for the assessment of the cellular immunity against SARS-CoV-2 Nature
Harnessing immune power against tumours - Roche
Targeting systemic IL-2 to BCMA CAR-T cells - Nature
Costimulation blockade in combination with IL-2 permits regulatory T cell sparing immunomodulatio...
Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexes - Sci...
Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexes Science | AAAS
Persistence of adoptively transferred T cells with a kinetically engineered IL-2 receptor agonist...
Persistence of adoptively transferred T cells with a kinetically engineered IL-2 receptor agonist Nature
Engineering IL-2 for immunotherapy of autoimmunity and cancer - Nature
Engineering IL-2 for immunotherapy of autoimmunity and cancer Nature
T cell exhaustion by activating the aryl hydrocarbon receptor - Nature
T cell exhaustion by activating the aryl hydrocarbon receptor Nature
Selective activation and expansion of regulatory T cells using lipid encapsulated mRNA encoding a...
A promising option for unremitting ulcerative colitis: Low-dose IL-2 - Boston Children's Answers
A promising option for unremitting ulcerative colitis: Low-dose IL-2 Boston Children's Answers
IL-2 imprints human naive B cell fate towards plasma cell through ERK/ELK1-mediated BACH2 repress...
IL-2 imprints human naive B cell fate towards plasma cell through ERK/ELK1-mediated BACH2 repression Nature
Spatial microniches of IL-2 combine with IL-10 to drive lung migratory T - Nature
Spatial microniches of IL-2 combine with IL-10 to drive lung migratory T Nature
Motor Neuron Disease Drug Safe and Effective at Low Doses - Technology Networks
Motor Neuron Disease Drug Safe and Effective at Low Doses Technology Networks
Differential IL-2 expression defines developmental fates of follicular versus nonfollicular helpe...
Differential IL-2 expression defines developmental fates of follicular versus nonfollicular helper T cells Science | AAAS
In wake of bempeg blowup, Sanofi rethinks $2.5B bet on IL-2 after midphase efficacy falls short -...
In wake of bempeg blowup, Sanofi rethinks $2.5B bet on IL-2 after midphase efficacy falls short Fierce Biotech
Salmonella-IL2 May Improve Upon FOLFIRINOX in Stage IV Pancreatic Cancer - Cancer Therapy Advisor
Salmonella-IL2 May Improve Upon FOLFIRINOX in Stage IV Pancreatic Cancer Cancer Therapy Advisor